Review article: a practical approach to the clinical management of NSAID enteropathy

References

• Pelletier J-P, Martel-Pelletier J, Rannou F, et al. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. 2015: Publisher.
   Google Scholar
• Lanas A, García-Rodríguez LA, Arroyo MT, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol. 2007;102:507–515.
   PubMed Web of Science ®Google Scholar
• Iddan G, Meron G, Glukhovsky A, et al. Wireless capsule endoscopy. Nature 2000;405:417
   PubMed Web of Science ®Google Scholar
• Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med. 1992;152:625–632.
   PubMedGoogle Scholar
• Huber T, Ruchti C, Halter F. Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. Gastroenterology 1991;100:1119–1122.
   PubMed Web of Science ®Google Scholar
• Tanner A, Raghunath A. Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problemDigestion 1988;41:116–120.
   PubMed Web of Science ®Google Scholar
• Lanas A, García-Rodríguez LA, Polo-Tomás M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104:1633–1641.
   PubMed Web of Science ®Google Scholar
• Graham DY, Opekun AR, Willingham FF, et al. Visible small-intestinal mucosal injury in chronic NSAID users. Clinical Gastroenterology and Hepatology. 2005;3:55–59.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clinical Gastroenterology and Hepatology. 2005;3:133–141.
   PubMed Web of Science ®Google Scholar
• Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005;128:1172–1178.
   PubMed Web of Science ®Google Scholar
• Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clinical Gastroenterology and Hepatology. 2007;5:1040–1045.
   PubMed Web of Science ®Google Scholar
• Fujimori S, Seo T, Gudis K, et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy . Gastrointest Endosc. 2009;69:1339–1346.
   PubMed Web of Science ®Google Scholar
• Fujimori S, Takahashi Y, Seo T, et al. Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy. Digestion 2010;82:167–172.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Prouse P, Smith T, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. The Lancet. 1987;330:711–714.
   Google Scholar
• Moore RA, Derry S, McQuay HJ. Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes. Arthritis Res Ther. 2008;10:R7.
   PubMed Web of Science ®Google Scholar
• Chan FK, Lanas A, Scheiman J, et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. The Lancet. 2010;376:173–179.
   PubMed Web of Science ®Google Scholar
• Forshaw M, Zayyan K, Power D. NSAID-induced small bowel perforation . ANZ J Surg. 2001;71:255–256.
   PubMed Web of Science ®Google Scholar
• Day T. Intestinal perforation associated with osmotic slow release indomethacin capsules. Br Med J (Clin Res Ed). 1983;287:1671.
   PubMed Web of Science ®Google Scholar
• Langman M, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed). 1985;290:347–349.
   PubMed Web of Science ®Google Scholar
• Coutrot S, Roland D, Barbier J, et al. Acute perforation of colonic diverticula associated with short-term indomethacin. Lancet. 1978;312:1055–1056.
   Web of Science ®Google Scholar
• Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327:749–754.
   PubMed Web of Science ®Google Scholar
• Lang J, Price A, Levi A, et al. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988;41:516–526.
   PubMed Web of Science ®Google Scholar
• Thiéfin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine. 2005;72:286–294.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Price A, Zanelli G, et al. Clinicopathological features of non-steroidal anti-inflammatory drug (NSAID) induced small intestinal strictures. 1988: Publisher.
   Google Scholar
• Flicek KT, Hara AK, Petris GD, et al. Diaphragm disease of the small bowel: a retrospective review of CT findings. Am J Roentgenol. 2014;202:W140.
   PubMed Web of Science ®Google Scholar
• Ishihara M, Ohmiya N, Nakamura M, et al. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease. Aliment Pharmacol Ther. 2014;40:538–547.
   PubMed Web of Science ®Google Scholar
• Cho KM, Park SY, Chung JO, et al. Risk factors for small bowel bleeding in chronic nonsteroidal anti-inflammatory drug users. J Dig Dis. 2015;16:499–504.
   PubMed Web of Science ®Google Scholar
• Pilotto A, Seripa D, Franceschi M, et al. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology. 2007;133:465–471.
   PubMed Web of Science ®Google Scholar
• Maehata Y, Esaki M, Morishita T, et al. Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam. J Gastroenterol. 2012;47:387–393.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Strom BL, Kimmel SE, et al. Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf. 2006;15:39–45.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Smith T, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987;93:480–489.
   PubMed Web of Science ®Google Scholar
• Park SC, Chun HJ, Kang CD, et al. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. WJG. 2011;17:4647–4653.
   PubMed Web of Science ®Google Scholar
• Tacheci I, Bradna P, Douda T, et al. NSAID-induced enteropathy in rheumatoid arthritis patients with chronic occult gastrointestinal bleeding: a prospective capsule endoscopy study. Gastroenterol Res Pract. 2013;2013:268382.
   PubMed Web of Science ®Google Scholar
• Herrerías Gutiérrez JM, Caunedo Álvarez Á, et al. Macroscopic small bowel injury caused by chronic NSAID consume assessed by capsule endoscopy. 2010.
   Google Scholar
• Barkin JS, Friedman S. Wireless Capsule Endoscopy requiring surgical intervention: the world’s experience. Am J Gastroenterol. 2002;97:S298.
   PubMed Web of Science ®Google Scholar
• Li F, Gurudu SR, De Petris G, et al. Retention of the capsule endoscope: a single-center experience of 1000 capsule endoscopy procedures. Gastrointest Endosc. 2008;68:174–180.
   PubMed Web of Science ®Google Scholar
• Frye JM, Hansel SL, Dolan SG, et al. NSAID enteropathy: appearance at CT and MR enterography in the age of multi-modality imaging and treatment. Abdom Imaging. 2015;40:1011–1025.
   PubMedGoogle Scholar
• Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 1987;107:513–516.
   PubMed Web of Science ®Google Scholar
• Felder JB, Korelitz BI, Rajapakse R, et al. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000;95:1949–1954.
   PubMed Web of Science ®Google Scholar
• Evans J, McMahon A, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 1997;40:619–622.
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Smale S, Premchand P, et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug–induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:196–202.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yoshida N, Nakabe N, et al. Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution. J Pharmacol Sci. 2008;106:469–477.
   PubMed Web of Science ®Google Scholar
• Niwa Y, Nakamura M, Ohmiya N, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol. 2008;43:270–276.
   PubMed Web of Science ®Google Scholar
• Zhang S, Qing Q, Bai Y, et al. Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis. Dig Dis Sci. 2013;58:1991–2000.
   PubMed Web of Science ®Google Scholar
• Park S-H, Cho C-S, Lee O-Y, et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled trial-STORM STUDY. J Clin Biochem Nutr. 2007;40:148–155.
   PubMed Web of Science ®Google Scholar
• Umegaki E, Kuramoto T, Kojima Y, et al. Geranylgeranylacetone, a Gastromucoprotective Drug, Protects Against NSAID-induced Esophageal, Gastroduodenal and Small Intestinal Mucosal Injury in Healthy Subjects: a prospective randomized study involving a comparison with famotidine. Intern Med. 2014;53:283–290.
   PubMed Web of Science ®Google Scholar
• Uejima M, Kinouchi T, Kataoka K, et al. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol Immunol. 1996;40:553–560.
   PubMed Web of Science ®Google Scholar
• Koga H, Aoyagi K, Matsumoto T, et al. Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin. Am J Physiol Gastrointest Liver Physiol. 1999;276:G576–GG82.
   Web of Science ®Google Scholar
• Scarpignato C, Dolak W, Lanas A, et al. Rifaximin Reduces Number and Severity of Intestinal Lesions Associated With use of Non-steroidal Anti-inflammatory Drugs in Humans. Gastroenterology. 2017;152:980–982.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Smethurst P, et al. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992;33:1204–1208.
   PubMed Web of Science ®Google Scholar
• Hayllar J, Smith T, Macpherson A, et al. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs . Arthritis Rheum. 1994;37:1146–1150.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hopkinson N, Zanelli G, et al. Treatment of non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1990;31:777–780.
   PubMed Web of Science ®Google Scholar
• Racz I, Szalai M, Kovacs V, et al. Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy. WJG. 2013;19:889–896.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Tanigawa T, Shiba M, et al. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients. Gut. 2014;63:409–414.
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Antonelli E, Distrutti E, et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology. 2005;129:1210–1224.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Blackler RW, Chan MV, et al. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal. 2015;22:398–410.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Jones JI, Atherton CT, et al. Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut. 2003;52:1537–1542.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Soldato PD. The therapeutic potential of NO‐NSAIDs. Fundam Clin Pharmacol. 2003;17:11–20.
   PubMed Web of Science ®Google Scholar
• Laine L, Curtis S, Cryer B, et al. Risk factors for NSAID‐associated upper GI clinical events in a long‐term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther. 2010;32:1240–1248.
   PubMed Web of Science ®Google Scholar
• Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728–738.
   PubMed Web of Science ®Google Scholar
• Huang J-Q, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359:14–22.
   PubMed Web of Science ®Google Scholar
• Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol. 2006;4:130–142.
   PubMed Web of Science ®Google Scholar
• Rodríguez LAG, Lin KJ, Hernández-Díaz S, et al. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation. 2011;123:1108–1115.
   PubMed Web of Science ®Google Scholar
• Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114:735–740.
   PubMed Web of Science ®Google Scholar
• Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:811–819.
   PubMed Web of Science ®Google Scholar
• Loke Y, Trivedi A, Singh S. Meta‐analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non‐steroidal anti‐inflammatory drugs. Aliment Pharmacol Ther. 2008; 27:31–40.
   PubMed Web of Science ®Google Scholar
• Richy F, Bruyère O, Ethgen O, et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis. 2004;63:759–766.
   PubMed Web of Science ®Google Scholar